Last reviewed · How we verify
CSL787
At a glance
| Generic name | CSL787 |
|---|---|
| Sponsor | CSL Behring |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB) (PHASE2)
- Study to Assess CSL787 in Non-cystic Fibrosis Bronchiectasis (NCFB) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |